ReN001

DB05236InvestigationalCell transplant therapies

ReN001 is a clonal human neural stem cell line developed for clinical use in the treatment of stable disability after stroke. ReN001 a strong candidate for one of the first... ReN001 a strong candidate for one of the first cell-based IND applications to be submitted to the Food and Drug Administration in the United States for consideration for the treatment of stroke in humans.

Mechanism: Pharmacologically active on Peroxisome proliferator-activated receptor delta
Curator reviewed
Primary indication: For the treatment of stroke.Curator reviewed
Code names: ReN001

Resolves to

Targets

Q03181PPARD

What you can answer from here — as of July 03, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with ReN001, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account